Overall Score

Growth

Revenue base remains very small at $0.63 per share, limiting scale.

No recent news indicates an acceleration in demand or expansion.

Profitability

TTM margins remain deeply negative, with gross margin at -9.9% and net margin at -344.8%.

Returns are still poor, with ROA at -44.2% and ROIC at -131.6%.

Financial Health

Balance sheet liquidity is extremely strong, with a current ratio of 31.9x and cash ratio of 23.3x.

Leverage remains minimal, with debt-to-equity at 0.01x and debt-to-assets at 1.1%.

Reinvestment

Capex remains light at 2.1% of revenue, suggesting limited capital intensity.

Stock-based compensation is elevated at 210.5% of revenue, which may dilute long-term equity growth.

Valuation

Valuation is not demanding on sales at 3.18x EV/Sales, but earnings and cash flow remain negative.

Price-to-book is 0.62x, reflecting a low multiple relative to book value.